John Marken
- Hematology top 2%
- Physiology top 5%
- Immunology top 10%
- T-cell and B-cell Immunology 6
- Immune Cell Function and Interaction 5
- Immune Response and Inflammation 2
- Genetics top 10%
- Diabetes and associated disorders 1
- Oncology top 10%
-
- Monoclonal and Polyclonal Antibodies Research 7
-
- Glycosylation and Glycoproteins Research 3
- Pluripotent Stem Cells Research 1
- CRISPR and Genetic Engineering 1
- Co-authors
- Sen-itiroh HakomoriThayer WhiteHenrik ClausenFumiichiro YamamotoAnne E. HughesStuart H. RalstonHeather MacPhersonL. Hovy
- Cited by
- HematologyPhysiologyImmunology
- Partner nations
- United StatesGermanyChina
In The Last Decade
John Marken
13 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Hematology 587
- Physiology 387
- Immunology 280
- Genetics 135
- Oncology 294
Countries citing papers authored by John Marken
This map shows the geographic impact of John Marken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Marken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Marken more than expected).
Fields of papers citing papers by John Marken
This network shows the impact of papers produced by John Marken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Marken. The network helps show where John Marken may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John Marken, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 9 | |
| 2 | 2021 | 15 | |
| 3 | 2021 | 1 | |
| 4 | 2019 | 57 | |
| 5 | 2016 | 2 | |
| 6 | 2015 | 14 | |
| 7 | 2012 | 6 | |
| 8 | 2000 | 353 | |
| 9 | 1995 | 53 | |
| 10 | 1995 | 6 | |
| 11 | 1995 | 66 | |
| 12 | 1994 | 22 | |
| 13 | Molecular genetic basis of the histo-blood group ABO systembreakdown → | 1990 | 869 |
About John Marken
John Marken is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy, having authored 13 papers that have together received 1.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (7 papers), T-cell and B-cell Immunology (6 papers), Immune Cell Function and Interaction (5 papers), Glycosylation and Glycoproteins Research (3 papers), Immune Response and Inflammation (2 papers), Diabetes and associated disorders (1 paper), Pluripotent Stem Cells Research (1 paper) and CRISPR and Genetic Engineering (1 paper). The work is most often cited by research in Hematology (587 citations), Physiology (387 citations) and Immunology (280 citations). John Marken has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Sen-itiroh Hakomori, Thayer White, Henrik Clausen, Fumiichiro Yamamoto, Anne E. Hughes, Stuart H. Ralston, Heather MacPherson, L. Hovy, Christine Bell and Wim Van Hul. Their work appears in journals such as Biochemistry, Arthritis Research & Therapy, Nature Genetics, The Journal of Immunology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.